Role of Adiponectin and Tumor Necrosis Factor-Alpha in the Pathogenesis and Evolution of Type 1 Diabetes Mellitus in Children and Adolescents.
adiponectin
tumor necrosis factor-alpha
type 1 diabetes mellitus
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
13 Nov 2020
13 Nov 2020
Historique:
received:
22
10
2020
revised:
04
11
2020
accepted:
11
11
2020
entrez:
18
11
2020
pubmed:
19
11
2020
medline:
19
11
2020
Statut:
epublish
Résumé
Type 1 diabetes mellitus (T1DM) is a complex condition caused by the destruction of pancreatic beta cells by autoimmune mechanisms. As a result, insulin deficiency and subsequent hyperglycemia occur. The aim of the present study is to investigate the role of adiponectin and tumor necrosis factor alpha (TNF-α) in the development of T1DM. The study is designed as an observational case-control study, involving 52 diabetic patients and 66 controls. Z scores for Body Mass Index (BMI), weight, height, and adiponectin and TNF-α serum levels were assessed in both groups. The T1DM group had significantly higher TNF-α levels and a significantly higher proportion of high-risk patients for inflammation based on TNF-α values as compared to the control group, while both groups had statistically similar adiponectin levels and a similar proportion of high/medium-risk patients based on adiponectin values. TNF-α plays a significant role in the pathogenesis and evolution of T1DM and it may represent an additional marker of disease progression, as well as a potential target of immunotherapeutic strategies. In the present study, no statistically significant differences were recorded in adiponectin levels neither in diabetic patients and controls, nor in high/medium severity risk diabetic patients.
Identifiants
pubmed: 33202729
pii: diagnostics10110945
doi: 10.3390/diagnostics10110945
pmc: PMC7697906
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Diabetes Complications. 2015 Jan-Feb;29(1):120-6
pubmed: 25113439
Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24
pubmed: 27979889
Iran J Pediatr. 2013 Jun;23(3):295-301
pubmed: 23795252
J Pediatr Endocrinol Metab. 2012;25(7-8):717-21
pubmed: 23155699
Rev Endocr Metab Disord. 2006 Sep;7(3):187-96
pubmed: 17131205
Pediatr Obes. 2017 Dec;12(6):468-476
pubmed: 27417272
J Clin Res Pediatr Endocrinol. 2009;1(5):233-9
pubmed: 21274300
J Clin Endocrinol Metab. 2012 Feb;97(2):463-72
pubmed: 22112811
Clin Exp Immunol. 2010 Sep;161(3):444-52
pubmed: 20529086
Mol Med. 2011 Jan-Feb;17(1-2):36-40
pubmed: 20838752
Clin Immunol. 2017 Jan;174:18-23
pubmed: 27871914
PLoS One. 2015 Dec 04;10(12):e0142976
pubmed: 26636339
J Endocrinol Invest. 2016 Dec;39(12):1425-1434
pubmed: 27541155
Diabetes Technol Ther. 2013 Aug;15(8):696-702
pubmed: 23902401
PLoS One. 2016 Jul 26;11(7):e0159808
pubmed: 27459718
Atherosclerosis. 2014 Nov;237(1):129-34
pubmed: 25238220
PLoS One. 2016 Aug 30;11(8):e0161548
pubmed: 27575603
Transl Res. 2018 Nov;201:13-25
pubmed: 30144424
Endocr J. 2011;58(12):1045-53
pubmed: 22033476
Pediatr Diabetes. 2016 Jun;17(4):249-56
pubmed: 25754190
Adv Med Sci. 2016 Mar;61(1):117-22
pubmed: 26647091
J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):174-81
pubmed: 24072086
PLoS One. 2017 Apr 20;12(4):e0176157
pubmed: 28426801
Eur Cardiol. 2019 Apr;14(1):50-59
pubmed: 31131037
Indian Pediatr. 2012 Apr;49(4):277-80
pubmed: 21992860
Pediatr Diabetes. 2018 Oct;19 Suppl 27:7-19
pubmed: 30226024
Pediatr Diabetes. 2018 Oct;19 Suppl 27:47-63
pubmed: 30225972
Nutr Hosp. 2015 Oct 01;32(4):1554-9
pubmed: 26545517
Acta Clin Belg. 2012 Mar-Apr;67(2):79-82
pubmed: 22712161
Eurasian J Med. 2011 Apr;43(1):18-22
pubmed: 25610154
J Pediatr (Rio J). 2016 Nov - Dec;92(6):624-630
pubmed: 27504976
Scand J Clin Lab Invest. 2009;69(1):85-91
pubmed: 18830896
J Diabetes Complications. 2018 Nov;32(11):995-999
pubmed: 30209019
Pediatr Diabetes. 2010 Feb;11(1):38-46
pubmed: 19496970
PLoS One. 2017 Apr 5;12(4):e0174840
pubmed: 28380011
J Diabetes Res. 2015;2015:730407
pubmed: 25950008
Front Endocrinol (Lausanne). 2019 Oct 30;10:703
pubmed: 31736870
J Pediatr Endocrinol Metab. 2019 Feb 25;32(2):109-113
pubmed: 30710485
Hum Immunol. 2013 Jan;74(1):75-81
pubmed: 23073299
Diabetes Care. 2004 Aug;27(8):2010-4
pubmed: 15277432
Acta Diabetol. 2015 Feb;52(1):167-74
pubmed: 25059225
Br J Nutr. 2016 Dec;116(11):1861-1868
pubmed: 27890035
Pediatr Diabetes. 2014 Dec;15(8):543-9
pubmed: 24978596
Immunol Cell Biol. 2017 Aug;95(7):630-639
pubmed: 28377612
J Diabetes Complications. 2017 Feb;31(2):369-374
pubmed: 27368123